Summary
patients treated
Has anyone ever benefited from stem cell?
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
List of patients
| No. | Source | Source type | Diagnosis | Medical sector | Year of application | Therapy | Country | Age of the recipient |
|---|---|---|---|---|---|---|---|---|
| 501 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 4 |
| 502 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 31 |
| 503 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
| 504 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 8 |
| 505 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 15 |
| 506 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 17 |
| 507 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 81 |
| 508 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 29 |
| 509 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 15 |
| 510 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 511 | Bone Marrow | Allogeneic | Sickle Cell Disease | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 512 | Bone Marrow | Allogeneic | T-Acute Lymphoblastic Leukemia, Ataxia Telangiectasia | Hematology | 2023 | Standard Therapy | Poland | 8 |
| 513 | Bone Marrow | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 16 |
| 514 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2023 | Standard Therapy | Poland | 2 |
| 515 | Bone Marrow | Allogeneic | Very Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 21 |
| 516 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 517 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2023 | Standard Therapy | Poland | 3 |
| 518 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 67 |
| 519 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 37 |
| 520 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
| 521 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 16 |
| 522 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 58 |
| 523 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 64 |
| 524 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 525 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
| 526 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 8 |
| 527 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 52 |
| 528 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 51 |
| 529 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 54 |
| 530 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 54 |
| 531 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 40 |
| 532 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 60 |
| 533 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 40 |
| 534 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 51 |
| 535 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 35 |
| 536 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
| 537 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
| 538 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 39 |
| 539 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 54 |
| 540 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 37 |
| 541 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 54 |
| 542 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 19 |
| 543 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 20 |
| 544 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 37 |
| 545 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 42 |
| 546 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 48 |
| 547 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 47 |
| 548 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 64 |
| 549 | Apheresis | Autologous | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 61 |
| 550 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 20 |
| 551 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
| 552 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 40 |
| 553 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 554 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 44 |
| 555 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 54 |
| 556 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 31 |
| 557 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 30 |
| 558 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 559 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia T-Cell; Myelodysplastic Syndrome" | Hematology | 2023 | Standard Therapy | Poland | 72 |
| 560 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Germany | 58 |
| 561 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Germany | 60 |
| 562 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 32 |
| 563 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 28 |
| 564 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 50 |
| 565 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 70 |
| 566 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 50 |
| 567 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 64 |
| 568 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 569 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 41 |
| 570 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 571 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 572 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 38 |
| 573 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 574 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 575 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 67 |
| 576 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 87 |
| 577 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 578 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 579 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
| 580 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 46 |
| 581 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 56 |
| 582 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 46 |
| 583 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 33 |
| 584 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 53 |
| 585 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 586 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 69 |
| 587 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 38 |
| 588 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 589 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 590 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 28 |
| 591 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 592 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 593 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
| 594 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 595 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 31 |
| 596 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 67 |
| 597 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
| 598 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 82 |
| 599 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
| 600 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |